virosome, virosom, virosomes, virosomal, Pevion Biotech, experts in vaccine design
Header


Pevion


Learn more about Pevion's first-in-class RVVC therapy

Pevion's Annual Report 2011 available here
© Pevion Biotech AG – Realisation WerbeLINIE
virosome, virosom, virosomes, virosomal, Pevion Biotech, experts in vaccine design

 > NEWS

08.03.2012
Pevion mandated patient survey confirms disease burden of recurrent vulvovaginal candidiasis (RVVC) and indicates public health problem
 
17.01.2012
Pevion’s therapeutic Candida vaccine generates functional B cell memory in all vaccinees


 > CONTACT
Pevion Biotech AG
Worblentalstrasse 32
3063 Ittigen / Bern
Schweiz
T +41 31 550 44 44
F +41 31 550 44 45
info@pevion.com




» downloads